INOZYME PHARMA, INC. Shares Outstanding
INOZYME PHARMA, INC. had Shares Outstanding of 64.47 million shares as of 2025-03-31, per its 10-Q filed 2025-05-14.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2025-05-14
- 2025-03-31: Common Stock, Shares, Outstanding 64.47M shares.
- 2024-12-31: Common Stock, Shares, Outstanding 64.24M shares.
- 2024-09-30: Common Stock, Shares, Outstanding 64.18M shares.
- 2024-06-30: Common Stock, Shares, Outstanding 62.07M shares.
| Period end | Common Stock, Shares, Outstanding |
|---|---|
| 2025-03-31 | 64.47M shares 10-Q · filed 2025-05-14 |
| 2024-12-31 | 64.24M shares 10-Q · filed 2025-05-14 |
| 2024-09-30 | 64.18M shares 10-Q · filed 2024-11-05 |
| 2024-06-30 | 62.07M shares 10-Q · filed 2024-08-06 |
| 2024-03-31 | 61.82M shares 10-Q · filed 2024-05-07 |
| 2023-12-31 | 61.77M shares 10-K · filed 2025-03-10 |
| 2023-09-30 | 61.76M shares 10-Q · filed 2023-11-07 |
| 2023-06-30 | 46.38M shares 10-Q · filed 2023-08-08 |
| 2023-03-31 | 43.77M shares 10-Q · filed 2023-05-09 |
| 2022-12-31 | 40.39M shares 10-K · filed 2024-03-12 |
| 2022-09-30 | 40.39M shares 10-Q · filed 2022-11-10 |
| 2022-06-30 | 40.10M shares 10-Q · filed 2022-08-15 |
| 2022-03-31 | 23.82M shares 10-Q · filed 2022-05-10 |
| 2021-12-31 | 23.67M shares 10-K · filed 2023-03-22 |
| 2021-09-30 | 23.66M shares 10-Q · filed 2021-11-09 |
| 2021-06-30 | 23.57M shares 10-Q · filed 2021-08-11 |
| 2021-03-31 | 23.47M shares 10-Q · filed 2021-05-12 |
| 2020-12-31 | 23.38M shares 10-K · filed 2022-03-15 |
| 2020-09-30 | 23.36M shares 10-Q · filed 2020-11-12 |
| 2020-06-30 | 1.34M shares 10-Q · filed 2020-09-03 |
| 2019-12-31 | 1.20M shares 10-K · filed 2021-03-25 |